FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

35139811000001102: Eyreida 0.3mg/ml eye drops (Aspire Pharma Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 21-Mar 2018. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
106384801000001114 Eyreida 0.3mg/ml eye drops (Aspire Pharma Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
106384901000001115 Eyreida 0.3mg/ml eye drops (Aspire Pharma Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Eyreida 0.3mg/ml eye drops (Aspire Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Eyreida 0.3mg/ml eye drops (Aspire Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Eyreida 0.3mg/ml eye drops (Aspire Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) freeness indicator Preservative free true Inferred relationship Existential restriction modifier
Eyreida 0.3mg/ml eye drops (Aspire Pharma Ltd) Has unit of administration drop true Inferred relationship Existential restriction modifier
Eyreida 0.3mg/ml eye drops (Aspire Pharma Ltd) Is a Bimatoprost 300micrograms/ml eye drops preservative free true Inferred relationship Existential restriction modifier
Eyreida 0.3mg/ml eye drops (Aspire Pharma Ltd) Has active ingredient Bimatoprost true Inferred relationship Existential restriction modifier
Eyreida 0.3mg/ml eye drops (Aspire Pharma Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Eyreida 0.3mg/ml eye drops (Aspire Pharma Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Eyreida 0.3mg/ml eye drops (Aspire Pharma Ltd) Has specific active ingredient Bimatoprost true Inferred relationship Existential restriction modifier
Eyreida 0.3mg/ml eye drops (Aspire Pharma Ltd) Has dispensed dose form Conventional release eye drops true Inferred relationship Existential restriction modifier
Eyreida 0.3mg/ml eye drops (Aspire Pharma Ltd) Has unit of administration drop false Inferred relationship Existential restriction modifier
Eyreida 0.3mg/ml eye drops (Aspire Pharma Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Eyreida 0.3mg/ml eye drops (Aspire Pharma Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Eyreida 0.3mg/ml eye drops (Aspire Pharma Ltd) Is a Eyreida true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Eyreida 0.3mg/ml eye drops (Aspire Pharma Ltd) 3 ml Has AMP True Eyreida 0.3mg/ml eye drops (Aspire Pharma Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start